Shield Therapeutics plc (STX.L)
LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
As of 10:51AM BST. Market open.
| Previous close | 1.3250 |
| Open | 1.3122 |
| Bid | 1.0500 x 0 |
| Ask | 1.1500 x 0 |
| Day's range | 1.0625 - 1.3122 |
| 52-week range | 1.0625 - 12.8500 |
| Volume | |
| Avg. volume | 6,177,054 |
| Market cap | 9.672M |
| Beta (5Y monthly) | 0.84 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.1200 |
| Earnings date | 30 Apr 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 26.00 |
Simply Wall St.Shield Therapeutics (LON:STX) shareholders have endured a 89% loss from investing in the stock three years ago
Every investor on earth makes bad calls sometimes. But you want to avoid the really big losses like the plague. So...
- Simply Wall St.
Shield Therapeutics plc (LON:STX) Is Expected To Breakeven In The Near Future
With the business potentially at an important milestone, we thought we'd take a closer look at Shield Therapeutics...
- Simply Wall St.
Shield Therapeutics First Half 2023 Earnings: US$0.025 loss per share (vs US$0.069 loss in 1H 2022)
Shield Therapeutics ( LON:STX ) First Half 2023 Results Key Financial Results Revenue: US$4.33m (up 69% from 1H 2022...
© 2024 Yahoo. All rights reserved.